Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Silcocks

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Contemporary Clinical Trials|May 30, 2009
Local recruitment experience in a study comparing the effectiveness of a low glycaemic index diet with a low calorie healthy eating approach at achieving weight loss and reducing the risk of endometrial cancer in women with polycystic ovary syndrome (PCOS)William Atiomo, Anna Read, Mary Golding, et al.
BMJ (Clinical Research Ed.)|August 20, 2009
Effects of dietary intervention and quadriceps strengthening exercises on pain and function in overweight people with knee pain: randomised controlled trialClaire M Jenkinson, Michael Doherty, Anthony J Avery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphomaJanet E Brown, Sue P Ellis, Paul Silcocks, et al.
Trials|January 11, 2018
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible: study protocol for a randomised controlled trialRichard Shaw, Christopher Butterworth, Binyam Tesfaye, et al.
International Journal of Radiation Oncology, Biology, Physics|March 10, 2019
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): A Randomized Controlled Trial of Hyperbaric Oxygen to Prevent Osteoradionecrosis of the Irradiated Mandible After Dentoalveolar SurgeryRichard J Shaw, Christopher J Butterworth, Paul Silcocks, et al.
The Lancet. Oncology|June 24, 2014
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trialGary Middleton, Paul Silcocks, Trevor Cox, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Contemporary Clinical Trials|May 30, 2009
Local recruitment experience in a study comparing the effectiveness of a low glycaemic index diet with a low calorie healthy eating approach at achieving weight loss and reducing the risk of endometrial cancer in women with polycystic ovary syndrome (PCOS)William Atiomo, Anna Read, Mary Golding, et al.
BMJ (Clinical Research Ed.)|August 20, 2009
Effects of dietary intervention and quadriceps strengthening exercises on pain and function in overweight people with knee pain: randomised controlled trialClaire M Jenkinson, Michael Doherty, Anthony J Avery, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphomaJanet E Brown, Sue P Ellis, Paul Silcocks, et al.
Trials|January 11, 2018
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): a randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible: study protocol for a randomised controlled trialRichard Shaw, Christopher Butterworth, Binyam Tesfaye, et al.
International Journal of Radiation Oncology, Biology, Physics|March 10, 2019
HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): A Randomized Controlled Trial of Hyperbaric Oxygen to Prevent Osteoradionecrosis of the Irradiated Mandible After Dentoalveolar SurgeryRichard J Shaw, Christopher J Butterworth, Paul Silcocks, et al.
The Lancet. Oncology|June 24, 2014
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trialGary Middleton, Paul Silcocks, Trevor Cox, et al.
Pageof 2